Asymchem Laboratories
Asymchem Laboratories, Inc. owns Asymchem Laboratories (Tianjin) Inc., a Chinese company established in 1998 that specializes in the research and development of pharmaceutical raw materials synthesis technology. This technology is integral to drug development and production, serving both large and medium-sized pharmaceutical companies in Europe and America. Asymchem Laboratories (Tianjin) Inc. boasts over 400 independent synthetic techniques and nearly 3,500 products, showcasing its extensive capabilities in the field. The company operates as a Contract Development and Manufacturing Organization (CDMO), offering solutions throughout the drug development and manufacturing process, including clinical and commercial stages. Its team consists of experienced professionals who have worked in significant pharmaceutical companies and American universities, contributing to its innovative approach and commercial application of pharmaceutical technology in both the Chinese mainland and international markets.
Top Stages
3 past transactions
Bio-Link
Series A in 2024
Bio-Link is a drug development company founded in 2001 and headquartered in Shanghai, China. It specializes in providing bioprocessing solutions for the life science industry, including the development and manufacturing of key process equipment and consumables. Bio-Link's offerings include technologies for vaccines, antibody drugs, cell therapy, gene therapy, and various biologics. The company focuses on upstream cell culture, disposable dispensing reservoirs, and downstream processes such as chromatography and ultrafiltration. By delivering innovative products and services, Bio-Link aims to enhance the efficiency, safety, and competitiveness of the biopharmaceutical supply chain. Additionally, the company explores wearable technology solutions for elderly care, further diversifying its portfolio.
Snapdragon Chemistry
Acquisition in 2022
Snapdragon Chemistry is a company based in Waltham, Massachusetts, focused on developing continuous flow chemistry solutions for the production of active pharmaceutical ingredients, intermediates, and materials. Founded in 2014, the company offers services including process development, reactor design and build, portfolio optimization, and GMP manufacturing. Snapdragon Chemistry addresses complex chemical transformations to create scalable synthetic processes for clients in pharmaceuticals, chemicals, animal care, and material science industries. The company was previously known as Firefly Chemistry before changing its name in April 2015.
LaNova Medicines
Series A in 2021
LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.